An exoskeleton is a mechanical device that improves, replaces and assists human movement, built from sensors, actuators, control systems and structural elements. The exoskeleton market was valued at approximately USD 582.67 million in 2025 and is expected to reach USD 1,953.42 million by 2034, registering a CAGR of 14.39% from 2026 to 2034, according to Polaris Market Research. North America dominated with a 40.50% share in 2025.

Rehabilitation Robotics Drives Healthcare Demand

Growing adoption of rehabilitation robotics is increasing demand across healthcare facilities. Hospitals and rehabilitation centers use these devices to improve patient mobility and speed recovery. Rehabilitation remained the leading application with a 45.80% share in 2025, owing to the number of patients recovering from stroke, spinal cord injuries and neurological disorders, while hospitals held the largest end-user share at 51.40%. Hospitals are also investing in modern rehabilitation equipment to ensure better treatment and offer more therapy services, and these investments are expected to sustain segment growth.

North America's lead reflects increasing adoption of robotic rehabilitation technologies and favorable reimbursement initiatives, along with investment by the U.S. and Canada in modern healthcare infrastructure. Rising government funding for rehabilitation programs and the need for mobility aids among the aging population further support demand.

Mobile and Stationary Systems

Mobile exoskeletons accounted for the largest mobility share at 62.30% in 2025. They let patients carry out everyday activities with better mobility and less physical exertion, and improvements in battery technology and lighter materials support further growth.

Stationary exoskeletons are expected to post the highest CAGR among mobility segments. Healthcare professionals increasingly use them for rehabilitation exercises that require controlled movements, and rising investment in advanced rehabilitation equipment should accelerate expansion.

Advances in Neurological Rehabilitation

Clinical progress is visible in neurological rehabilitation. In November 2025, U.S. FDA approval of Wandercraft's Atalante X was broadened to cover people with multiple sclerosis and high-level spinal cord injuries. In June 2026, Northwestern University developed a robotic therapy system to improve gait rehabilitation and walking recovery for stroke survivors, and Severance Hospital in South Korea started a government-supported initiative to develop brain-controlled wearable exoskeletons for quadriplegics.

In December 2025, Verita Neuro and Lifeward added the ReWalk Personal Robotic Exoskeleton to a spinal cord injury rehabilitation program in the UAE. ETH Zurich also introduced the AI-based MAYO Suit in June 2026 to ease walking for senior adults and people with mobility issues.

Technology is supporting these outcomes. AI provides real-time motion assistance that improves movement accuracy, and motion sensors enable precise movement detection that improves rehabilitation outcomes.

Browse More Information:

https://www.polarismarketresearch.com/industry-analysis/exoskeleton-market 

Medical Exoskeletons: Regulation, Cost and Barriers

Medical exoskeletons operate within established regulatory frameworks, including FDA medical device regulations in the U.S., the EU Medical Device Regulation in Germany and UK medical device regulations. Rehabilitation systems carry an estimated price range of USD 40,000–120,000, reflecting medical-grade robotics.

High prices and limited reimbursement remain the main restraints, especially in emerging markets. Entry barriers include costly development, complex approvals and the need for continuous product testing and clinical validation.

Competitive Landscape

The market is moderately fragmented, with competition driven by product performance, light weight, battery power, software integration and therapeutic effects.

Key Players

• CYBERDYNE Inc.
• Ekso Bionics Holdings, Inc.
• German Bionic Systems GmbH
• Honda Motor Co., Ltd.
• Lockheed Martin Corporation
• Ottobock SE & Co. KGaA
• Parker Hannifin Corporation
• ReWalk Robotics Ltd.
• Sarcos Technology and Robotics Corporation
• SUITX
• Wandercraft SAS
• Wearable Robotics Srl

CYBERDYNE is positioned in medical rehabilitation robotics with an Asia Pacific focus, Ottobock in orthopedic and rehabilitation solutions and Wandercraft in self-balancing rehabilitation exoskeletons in Europe. Asia Pacific is the fastest-growing region.

Conclusion

Clinical demand is a defining force in the exoskeleton market. Hospitals and rehabilitation centers are investing in robotic therapy, regulators are approving expanded uses and new products are targeting stroke, spinal cord injury and mobility needs. Companies that can lower costs, secure reimbursement and prove clinical outcomes stand to benefit as adoption widens.

More Trending Latest Reports By Polaris Market Research:

Biogas Market

Sinus Dilation Devices Market

Bakery Contract Manufacturing Market

Folic Acid Market

Synthetic Gypsum Market

Mycoplasma Testing Market

Mycoplasma Testing Market

Bakery Contract Manufacturing Market

Bpo Business Analytics Market